Trial NCT03041701

View at ClinicalTrials.gov 
Org. Study IDs: 170049
Secondary IDs: 17-C-0049

Last trial update was posted on 2022-04-14

MeSH Interventions

Dasatinib

MeSH Conditions

Rhabdomyosarcoma Rhabdomyosarcoma, Alveolar Rhabdomyosarcoma, Embryonal

Other Conditions


Stopping Reasons

The pharmaceutical company discontinued availability of the drug and we were forced to close the study before phase II was completed. Only one participant was enrolled on phase II.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID